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Summary
Whether resident and recruited myeloid cells may impair or aid healing
of acute skin wounds remains a debated question. To begin to address
this, we examined the importance of CD11c+ myeloid cells in the early
activation of skin wound repair. We find that an absence of CD11c+ cells
delays wound closure and epidermal proliferation, likely due to defects in
the activation of the IL-23-IL-22 axis that is required for wound healing.
Keywords: CD11c; dendritic cells; Langerhans cells; skin; wound repair.
To the Editor,
Wound healing in healthy skin requires a complex
interplay between immune and non-immune cells. In
addition to their roles in infection control and cell
debridement, leukocytes secrete factors to orchestrate the
timing of the repair process via crosstalk with epithelia.
This critical role in wound timing is vital as failure to
induce wound closure leads to debilitating chronic
wounds susceptible to further infection and patient sepsis.
We have shown that injury-induced activation of Notch
signalling results in recruitment of type 3 innate lym-
phoid cells (ILC3s) that control macrophage recruitment
and epidermal closure.1 Injury also initiates the rapid
influx of innate myeloid cells to the skin; this influx is
Abbreviations: cDC, conventional dendritic cell; DC, dendritic cell; dpw, days post-wounding; DT, diphtheria toxin; DTR, diph-
theria toxin receptor; ILC3, type 3 innate lymphoid cell; LC, Langerhans cell; mRNA, messenger ribonucleic acid; PBS, phos-
phate-buffered saline
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initially dominated by neutrophils, followed by mono-
cytes and dendritic cells (DCs).2 But whether innate mye-
loid cells help or hinder processes initiated by ILC3s is
unclear. Moreover, resident myeloid cells such as epider-
mal Langerhans cells (LCs) will be destroyed upon tissue
destruction. Whether and how these cells are important
during the earliest activation of the wound healing
response remains to be elucidated.
Focused on these questions, we read with interest the
recent Immunology study by Rajesh et al.,3 in which they
investigated skin wound healing in mice depleted of Lan-
gerin+ LCs and dermal conventional type 1 DCs (cDC1s),
using the Langerin-DTR (diphtheria toxin receptor)
mouse. The authors demonstrated an initial acceleration
in wound closure in skin lacking Langerin+ cells, which
they suggested was consistent with the known negative or
regulatory role for resident LCs in skin immunity.4 We
have recently conducted a complementary study in which
we ablated CD11c+ cells, including LCs, cDCs and other
myeloid cells, in the CD11c-DTR model to investigate the
impact on closure of cutaneous wounds. In contrast to
Ranjesh et al., we observed a marked delay in wound
healing in the absence of these cells. We believe that com-
parison of these in vivo ablation studies, in which differ-
ent but overlapping populations of cells were deleted
before wounding, reveals novel insights into the role of
myeloid cells in cutaneous wound repair that will be of
interest to your readers.
Methods and materials
Mice and wounds
CD11c.DTR mice (on the B6 background) were bought
from the Jackson Laboratories and bred in-house. Mice
were wounded in accordance with methods published in
Li et al. (2016) and Li et al. (2018).1,5 Briefly, anaes-
thetized mice were given two full-thickness, 4-mm-di-
ameter back skin wounds with a minimum distance of
1 cm apart using a punch biopsy (Stiefel). Two days
prior to and on the day of wounding, mice were
injected intraperitoneally with two doses of 100 ng
diphtheria toxin (DT, Sigma, D0564) or PBS. All exper-
imental procedures were performed with ethical permis-
sion by Durham University and the University of York
under UK Government Home Office licences to CA and
MC (60/3941 and 60/4178). Experiments followed the
national and institutional guidelines for the care and
use of animals on the basis of the Animal (Scientific
Procedures) Act 1986 and where possible ARRIVE
guidelines.
Wounds were photographed using a 3D camera (Quan-
tificare) on day 5 after injury. Each wound was pho-
tographed three times, with each image analysed three
times to check for measurement consistency. A random
code was assigned to each image, and blind analysis was
carried out using the Dermapix software (Quantificare).
Flow cytometry
Quantification of immune cells within the skin wounds
by flow cytometry was performed as previously
described.1,5 An 8 9 8 mm piece of mouse back skin
including the wounded area and adjacent area was col-
lected, and the ventral surface was scraped gently with a
scalpel to remove subcutaneous fat and muscle. Tissue
was cut into 4–5 smaller pieces and incubated with
035 mg/ml Liberase TL (Roche, 5401020001), 3 mg/ml
Collagenase D (Roche, 11088866001) and 01 mg/ml
DNase I (Roche, 10104159001) in a volume of 700 µl
RPMI-1640 (Life Technologies, 31870-025) on a heating
shaker at 37 °C for 2 h. After incubation, undigested deb-
ris was removed by filtering the sample through a 70-µm
strainer. Cells were harvested by centrifuging at 400 g at
4°C for 5 min and resuspended in FACS staining buffer
(05% BSA, 2 mM EDTA in PBS). Following incubation
with anti-CD16/32 (BioLegend, 101320, 1:100) and rat
IgG (Sigma, Cat: I8015-10 mg; 1:1000) diluted in FACS
staining buffer, cells were stained for viability dye eFluor
780 (Thermo Fisher, 65-0865, 1:1500) and surface mark-
ers on ice for 30 minutes by using the following antibod-
ies: CD11b PE-Cy7 (BioLegend, M1/70, 101215, 1:1000),
CD11c pacific blue (Thermo Fisher, N418, 117321,
1:200), CD45 PerCP-Cy55 (BioLegend, 30-F11, 103131,
1:100), CD207 PE (BioLegend, 4C7, 144203, 1:200) and
F4/80 APC (eBioscience, BM8, 17-4801, 1:400). Data were
acquired on an LSR Fortessa (BD) and analysed with
FlowJo and GraphPad Prism software.
Immunostaining
Tissue was collected and processed as previously
described.1 8-lm-thick frozen tissues were fixed in 4%
paraformaldehyde, blocked in 10% goat or donkey serum,
025% fish skin gelatine and 02% bovine serum albumin
and then stained with purified anti-Ki67 antibody
(Abcam, ab16667, 1:400) diluted in permeabilization buf-
fer (Thermo Fisher, 00-8333, 1:10) for 1 h. Tissue sec-
tions were stained with Alexa Fluor 488 secondary
antibody (Thermo Fisher, A11008, 1:1000) and DAPI-
counterstained before imaging using a Leica Tandem SP5
confocal microscope. The brightness of images was
adjusted using the ImageJ software.
RNA extraction and quantitative RT-PCR
8 9 8 mm wounded back skin tissues were collected, and
RNA was extracted from tissues immersed in RNAlater
(Merck, R0901) for 24 h before freezing. Tissues were
homogenized using Polytron tissue homogenizer, and
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then, RNA was isolated using RNeasy Mini Kit (Qiagen,
74104) following the manufacturer’s instructions includ-
ing the optional, on-column DNase I digestion step using
RNase-free DNase set (Qiagen, 79254). An additional
proteinase K digestion step was performed in the proto-
col: homogenized lysates were incubated with 02 mg/ml
proteinase K (Merck, P2308) in RLT buffer (Qiagen) at
55°C for 10 min. Harvested RNAs were quantified using
a NanoDrop microspectrophotometer, and cDNA was
prepared using the High Capacity cDNA Transcription
Kit (Thermo Fisher, 4368814).
FAM-labelled TaqManTM probes were used for IL-22
(Mm01226722_g1; Thermo Fisher) and endogenous con-
trol GAPDH (Mm99999915_g1; Thermo Fisher). Tripli-
cate reactions (20 ll) of each experimental sample were
analysed using TaqManTM Fast Universal PCR Master
Mix (Thermo Fisher, 4352042) and subjected to an initial
3-min denaturation step at 95 °C, followed by 40 cycles
of 95°C for 3 s and 60°C for 10 s.
Unlabelled primers were used for IL23a p19
(NM_0312522, Forward 50-TGGAGCAACTTCACAC-
CTCC-30, Reverse 50-GGCAGCTATGGCCAAAAAGG-30)
and endogenous control beta-2 microglobulin (B2M,
NM_0097353, Forward 50-GTCGCTTCAGTCGTCAG-
CAT-30, Reverse 50-TTTCAATGTGAGGCGGGTGG-30).
Triplicate reactions (20 ll) of each experimental sample
were analysed using SYBR Green JumpStartTM Taq Ready-
MixTM (Merck, S1816) and subjected to an initial 3-min
denaturation step at 95 °C, followed by 40 cycles of 95°C
for 10 s, 60°C for 10 s and 72°C for 10 s.
RT-PCR was performed using a Rotor-Gene Q instru-
ment (Qiagen). Data were analysed using the comparative
quantification algorithm in the Rotor-Gene software, with
calibrator samples for each run being compared in a
common experiment.
Results and discussion
We examined the effects of acute damage on the kinetics
of resident and recruited CD11c+ cells by flow cytometry,
which allowed for precise cell quantification. Using meth-
ods detailed in our previously published work,5 cell popu-
lations were investigated in a 8 mm 9 8 mm skin sample
consisting of the wound bed and adjacent uninjured skin
during the inflammatory stage at 1–3 days post-wounding
(dpw) and re-epithelization at 8 dpw (Fig. 1A). Cuta-
neous wounding triggers a rapid transient influx and/or
expansion of CD45+ immune cells at the damaged site;
the percentage of CD45+ immune cells had more than
trebled immediately after injury 1 dpw and remained high
at 1–3 dpw compared with unwounded skin, but had
returned towards baseline levels by day 8 dpw (Fig. 1B).
Focusing on CD11c+ cells, we observed an early relative
reduction in the frequency of CD11c+ cells as a propor-
tion of CD45+ cells (Fig. 1B), in line with the rapid influx
of neutrophils that occurs immediately after wounding.2
As the numbers of CD45+ immune cells declined post-
wounding, the proportion of CD11c+ cells increased, sug-
gesting that these cells were becoming a more dominant
part of the wound healing response from 3 dpw
(Fig. 1C). Parsing of the CD11c+ population demon-
strated that the majority of CD11c+ cells were
CD11chighCD11bint to high cells, which are expected to
contain cDC2 and monocyte-derived DC, although acti-
vated monocytes and macrophages were not formally
excluded from this gate. CD11chighCD11bint to high cells
were diminished upon wounding but rapidly returned to
baseline levels by 2 dpw, suggesting rapid recruitment to
the wound bed. By comparison, we did not observe dif-
ferences in the CD11chighCD11bneg fraction (including
Langerin+ cDC1) during the time course. Rajesh et al.
quantified LC numbers by immunohistochemistry at and
around the wound bed and demonstrated the destruction
of resident LC followed by the apparent repopulation of
the epidermis by 9 dpw.3 Our flow cytometric analysis
also revealed the dramatic loss of LC on wounding, with
gradual return of CD11bintCD207+ cells over time. How-
ever, we and others2 found LC frequency had not
returned to baseline by 8 dpw (Fig. 1A-C). Our studies
and that of Rajesh et al. did not address the origin of the
repopulating LC, which may be derived from dividing
resident embryo-derived LC and/or monocytes recruited
to the inflamed site. However, it was notable that repopu-
lation of LC was preceded by the increase in
CD11chighCD11bint to high cells in our study, which may
contain monocytic LC precursors.6
To determine the role of CD11c+ cells in wound clo-
sure, we used the CD11c-DTR mouse model in which
injection of diphtheria toxin (DT) results in the rapid
inducible deletion of cells expressing a high-affinity
DTR.7,8 CD11c-DTR littermate mice were injected with
DT or PBS, as vehicle control, 2 days prior to wounding
and on the day of injury (Fig. 2A). This protocol resulted
in the efficient and sustained deletion of CD11c+
CD11bneg to high cells and CD11c+CD11bintCD207+ LC
(Fig. 2B,C). There was no difference in the frequency of
CD11cnegCD11b+ F4/80+ macrophages, which comprise a
significant proportion of CD45+ cells at wound sites,1,2
upon injection of DT (Fig. 2D).
To examine the impact of CD11c cell depletion on
healing, wound size was measured in PBS- or DT-injected
mice for up to 5 days following injury, as previously
described5 (Fig. 2E). Notably, wounds failed to re-epithe-
lialize and remained fully open in DT-treated CD11c-
DTR mice (average openness 964%, n = 6) compared
with PBS-treated littermates (average openness 373%,
n = 6) at 5 dpw (Fig. 2F). The re-epithelialization phase
of repair is marked by extensive proliferation in the epi-
dermis at the wound edge and in the dermal fibrob-
lasts.9,10 In DT-treated CD11c-DTR mice, reduced
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Figure 1. Flow cytometric analysis of CD11c+ populations in wounds. Mice were received 4-mm full skin thickness wounds and the skin
immunophenotyped at different time-points. (A) Representative contour plots showing gated CD11c populations in wounded back skin at suc-
cessive time-points post-wounding. Cells were pre-gated on single live cells. Summary bar graphs show (B) the mean frequency  SD of gated
cells, calculated as a percentage of the total live skin cells or (C) of the CD45+ population for wounds 1, 2, 3 and 8 dpw. Averages are of three
biological replicates. Each time-point was compared with unwounded skin using the pairwise comparison t-test with the Welsh correction.
*P ≤ 005; **P ≤ 001; ***P ≤ 0001; NS, not significant.
Figure 2. Ablation of CD11c+ cells delays wound closure and IL-23/IL-22 production in wounds. (A) Schematic showing the experimental proto-
col. CD11c-DTR mice were injected with DT or PBS, as a control, 2 days prior to and on the day of wounding. (B-D) Wounds were
immunophenotyped by flow cytometry. Summary bar graphs show the mean frequency  SD of all (B) CD11c+ cells (C), CD11bintCD207+ LCs
and (D) CD11cnegCD11b+F4/80+ macrophages among total CD45+ cells, in unwounded (D0) and 1, 2 or 3 dpw in both DT-treated and PBS-
treated CD11c-DTR mice. Data are from three biological replicates. (E) Representative images of wounded PBS-treated and DT-treated CD11c-
DTR mice 5 dpw. (F) Wounds were photographed, and size was calculated as a percentage of the wound size on the day of wounding. Graphs
show individual mice with lines at the mean. (G) Sections of wounds 5 dpw from PBS- and DT-treated mice stained with an antibody to Ki67
(green) and costained with DAPI (blue). Red arrows indicate representative positive staining, and red asterisks mark epidermis adjacent to wound
sites. Scale bars equal 100 microns. (H and I) qPCR quantification of IL-23 and IL-22 in total wound skin from PBS- and DT-treated CD11c-
DTR mice analysed 2 and 5 dpw. Graphs show individual samples, with lines at mean  SD, n = 9–12. Each time-point was compared with
unwounded skin (B-D) or PBS-treated control at 2 or 5 dpw (H and I) using the pairwise comparison t-test with the Welsh correction.
*P ≤ 005; **P ≤ 001; ***P ≤ 0001; and ****P ≤ 00001; NS, not significant.
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proliferation in both compartments was detected by
immunostaining with proliferation marker, Ki67, on sec-
tioned wounds (Fig. 2G). This suggested that a reduction
in cell proliferation contributed to the healing failure in
these mice. Epidermal thickening at the wound edge was
also reduced compared with PBS-treated control wounds
with only rare Ki67+ cells detected in the epidermis
(Fig. 2G, arrows). Our and others’ work has shown that
wound-induced infiltration of macrophages plays key
roles in the re-epithelialization phase of tissue repair.1,11
However as we did not detect changes in F4/80+ macro-
phages (Fig. 2D) our data suggested that loss of other
CD11c+ cells, rather than a defective macrophage com-
partment, was the cause of aberrant wound closure
observed in these mice. Together with our previous
study,1 these findings imply non-redundant roles for
innate lymphoid and myeloid cells in cutaneous wound
healing.
This absence of changes in macrophage frequency
appears to differ from Rajesh et al., who detected an
increase in the number of F4/80+ cells by immunohisto-
chemistry 6 dpw.3 This difference may reflect the
methodologies used to quantify cells, and different time-
points tested. However, it is also possible that broader
depletion of all CD11c+ cells from our model, but not the
Langerin-DTR mouse, resulted in loss of precursors and/
or cytokine-producing cells that seeded the expanded F4/
80+ pool in the skin. Neither study specifically considered
the role of monocytes as either effector cells or precursors
to other cells in the wound healing response. But, it is
interesting to note that the increase in GM-CSF upon
deletion of Langerin+ cells observed by Rajesh et al.3
would directly impact on differentiation of monocytes
into moDC in the dermis.
The decrease in the rate of wound closure upon loss of
CD11c+ cells was in striking contrast to that of Rajesh
et al. who demonstrated that injection of DT into Lan-
gerin-DTR mice prior to, and after, wounding by excision
of full-thickness skin biopsies led to an initial rapid con-
traction of the wound.3 Subsequent closure in the latter
study occurred at a similar rate to control animals, but
the acceleration of healing within the first 24 h led to fas-
ter overall wound closure in skin depleted of Langerin+
cells. Thus, the absence of overlapping, but different, pop-
ulations of myeloid cells appears to have a distinct and
contrasting impact on the initiation of wound repair;
whilst depletion of CD11c+ cells, including LCs, dermal
cDCs and moDCs, in our study delayed wound closure,
specific ablation of LC and Langerin+ cDC1 prior to
wounding accelerated the healing response.3 The DT-me-
diated absence of LCs from the skin before wounding in
our study and that of Rajesh et al. (2020) may point
towards the importance of LC in maintaining a regulated
homeostatic immune environment in the absence of
infection; indeed, LC numbers are decreased in non-
wounded skin of db/db diabetic mice that are susceptible
to chronic wounding,2 and recent analysis of transcrip-
tional networks within human LCs has revealed default
pathways of tolerance in the absence of infectious sig-
nals.12 Subtle differences between these studies such as
use of analgesia and animal cohousing conditions may
impact outcomes; the use of antibiotics by Rajesh et al.,
but not in our study, will alter local cutaneous and sys-
temic microbiota, which could alter immune cell dynam-
ics and the rate of wound closure.13 It is also possible
that, as we did not analyse the very early time-points
post-wounding, LC-dependent accelerated wound shrink-
age within 24 h of wounding may also occur in our
CD11c-DTR model. However, we propose that the
absence of recruited CD11c+ DCs at later time-points
overrides any impact of early loss of LC and ultimately
dominates to delay healing.
Key roles for the IL-23/IL-22 signalling axis have been
defined in facilitating immune–non-immune cell crosstalk
leading to wound closure.9–12 To gain insight into the
mechanisms by which CD11c+ cells may impact on
wound repair, we examined the mRNA levels of IL-23/IL-
22 in wounded CD11c-DTR mice. IL-23 mRNA levels
were significantly lower in CD11c-depleted wounds at 5
dpw (data at 2 dpw were not statistically significant)
compared with normal wounds, whilst IL-22 mRNA
levels were lower at both 2 and 5 dpw in DT-treated
wounds. These results suggest that CD11c+ populations
contribute to the earliest stages of skin repair, in part,
through regulation of localized IL-22/IL-23 expression in
skin wounds.
Influx of moDC/cDC2 to the wound site has been
demonstrated by others2 and points towards a key role
in healing. Whilst we did not specifically identify these
cells, we also observed accumulation of CD11c+CD11b+
cells at the wound site. DT injection ablated
CD11c+CD11b+ cells in our CD11c model, but they
would have been present in DT-injected Langerin-DTR
mice3 and may therefore contribute to the difference in
our findings. Psoriasis may be viewed as aberrant activa-
tion of the wound closure response. Here, DC IL-23
stimulates dermal Th17 cells to produce IL-17A and, to
a lesser extent, IL-22, which drive the hallmarks of this
pathology.12 We speculate that recruited moDCs/cDC2s
contribute to the formation of the new epidermis; dele-
tion of IL-23-producing moDCs/cDC2s in the CD11c-
DTR model prevents initiation of the IL-22-dependent
proliferation and differentiation of keratinocytes, ulti-
mately preventing the efficient healing of the acute
wound. More detailed phenotyping of skin myeloid cells
is required to test this hypothesis. However, in support
for a key role for DC, there is evidence to suggest that a
role for DCs could be conserved across different types of
skin injury; depletion of CD11c+ cells in the CD11c-DTR
model also delayed healing of burn wounds, whilst
ª 2021 The Authors. Immunology published by John Wiley & Sons Ltd.6
injection of the growth factor FLt3L to increase DC
numbers was sufficient to accelerate healing.14
In summary, whilst neither study provide the resolu-
tion to distinguish between the specific roles of LC and
DC in wound healing, together they begin to shed light
on the ways in which resident and recruited myeloid cells
may impair or aid acute skin wound closure during the
orchestrated process of healing. Defining these mecha-
nisms has important clinical implications for improving
the outcome of chronic wounds.
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